Q1 outperformance and disciplined cost control offset exchange and respiratory headwinds; management reaffirmed 2026 guidance.
| Quarter | Q1 FY26 |
|---|---|
| Call date | 2026-04-30 |
| Length | 54 minutes |
| EPS | $4.82 |
| EPS consensus | $4.21 |
| Revenue | $5.4B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q4 FY25 · Q2 FY25
All THC earnings · Back to THC overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.